Sale of Securities

Tarsus Pharmaceuticals, Inc. Filed 2026-09-04 Acc 0001628280-26-060766

Documents 1

2026-09-04 144 Sale of Securities
2026-09-04 144 Sale of Securities
2026-09-04 144 Sale of Securities
2026-09-04 144 Sale of Securities
2026-09-03 4 Chief Medical Officer sold 11,578 shares at an average $77.56 ($897,990)
2026-09-03 4 President/CEO and Board Chair sold 10,000 shares at $80.06 ($800,600)
2026-09-02 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…